MedPath

Translational Drug Development

๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
-
Employees
-
Market Cap
-
Website

Study Evaluating the Ketogenic Diet in Patients with Metastatic Pancreatic Cancer

Not Applicable
Completed
Conditions
Metastatic Pancreatic Ductal Adenocarcinoma
Interventions
Other: Ketogenic Diet
First Posted Date
2020-11-17
Last Posted Date
2025-02-21
Lead Sponsor
Translational Drug Development
Target Recruit Count
32
Registration Number
NCT04631445
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Honor Health, Scottsdale, Arizona, United States

๐Ÿ‡บ๐Ÿ‡ธ

USC/Norris Comprehensive Cancer Center, Los Angeles, California, United States

๐Ÿ‡บ๐Ÿ‡ธ

Nuvance Health-Danbury Hospital, Danbury,, Connecticut, United States

and more 3 locations

A Pilot Study Utilizing Proteomic and Genomic Profiling for Patients With Metastatic Breast Cancer

Not Applicable
Completed
Conditions
Metastatic Breast Cancer
Interventions
Other: treated recommended
First Posted Date
2013-08-09
Last Posted Date
2023-03-28
Lead Sponsor
Translational Drug Development
Target Recruit Count
25
Registration Number
NCT01919749
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Mayo Clinic, Scottsdale, Arizona, United States

๐Ÿ‡บ๐Ÿ‡ธ

Virginia Cancer Specialists, Fairfax, Virginia, United States

A Study of Therapy Selected by Molecular/Metabolic Profiling in Patients With Previously Treated Metastatic Pancreatic Cancer

Phase 2
Completed
Conditions
Previously Treated Metastatic Pancreatic Cancer
First Posted Date
2010-09-08
Last Posted Date
2012-07-17
Lead Sponsor
Translational Drug Development
Target Recruit Count
35
Registration Number
NCT01196247
Locations
๐Ÿ‡บ๐Ÿ‡ธ

TGen Clinical Research Services at Scottsdale Healthcare, Scottsdale, Arizona, United States

Pilot Study Using Molecular Profiling to Find Potential Targets & Select Treatments for Pts With Met br ca

Early Phase 1
Completed
Conditions
Metastatic Breast Cancer
Interventions
Drug: Approved therapy will be assigned based on molecular profile and RPMA results
First Posted Date
2010-02-24
Last Posted Date
2023-09-28
Lead Sponsor
Translational Drug Development
Target Recruit Count
28
Registration Number
NCT01074814
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Evergreen Hematology and Oncology, Spokane, Washington, United States

๐Ÿ‡บ๐Ÿ‡ธ

Fairfax North Virginia Hematology Oncology, Fairfax, Virginia, United States

๐Ÿ‡บ๐Ÿ‡ธ

Tgen Clinical Research Services, Scottsdale, Arizona, United States

ยฉ Copyright 2025. All Rights Reserved by MedPath